Palladyne AI: The Right Vision In The Right Market, But Still Too Early To Buy

Palladyne AI Corp.'s technology is compelling, but the company is in an early commercialization stage. Read why PDYN stock is ...
techiboy

CMF Phone 1 Updated to Nothing OS 3.2 (September Patch) Ahead of Major OS 4.0 Release

Nothing has released a new OTA update for the CMF Phone 1. This update is based on Nothing OS 3.2 (September patch) and mainly focuses on improving system performance and fixing minor bugs. Even ...
CURE

Enhertu Reduces Risk of Invasive Disease or Death in HER2+ Breast Cancer

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...
Fierce Pharma

ESMO: Merck spotlights details of Keytruda's landmark win in ovarian cancer

Merck’s efforts to make headway in a cancer type that was an elusive target for its superstar oncology med Keytruda proves to ...